252 related articles for article (PubMed ID: 38973)
1. Nigrostriatal lesions enhance striatal 3H-apomorphine and 3H-spiroperidol binding.
Creese I; Snyder SH
Eur J Pharmacol; 1979 Jun; 56(3):277-81. PubMed ID: 38973
[TBL] [Abstract][Full Text] [Related]
2. Quantitative analysis of [3H]spiroperidol binding to rat forebrain sections: plasticity of neostriatal dopamine receptors after nigrostriatal injury.
Neve KA; Altar CA; Wong CA; Marshall JF
Brain Res; 1984 Jun; 302(1):9-18. PubMed ID: 6428705
[TBL] [Abstract][Full Text] [Related]
3. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
Quik M; Emson PC; Joyce E
Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
[TBL] [Abstract][Full Text] [Related]
4. Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat.
Hall MD; Jenner P; Kelly E; Marsden CD
Br J Pharmacol; 1983 Jun; 79(2):599-610. PubMed ID: 6418246
[TBL] [Abstract][Full Text] [Related]
5. Dopamine antagonist binding increases in two behaviorally distinct striatal denervation syndromes.
Thal L; Mishra RK; Gardner EL; Horowitz SG; Varmuza S; Makman MH
Brain Res; 1979 Jul; 170(2):381-6. PubMed ID: 572733
[No Abstract] [Full Text] [Related]
6. The relationship between loss of dopamine nerve terminals, striatal [3H]spiroperidol binding and rotational behavior in unilaterally 6-hydroxydopamine-lesioned rats.
Heikkila RE; Shapiro BS; Duvoisin RC
Brain Res; 1981 May; 211(2):285-92. PubMed ID: 7237124
[TBL] [Abstract][Full Text] [Related]
7. Chronic lithium administration alters behavioral recovery from nigrostriatal injury: effects on neostriatal [3H]spiroperidol binding sites.
Kozlowski MR; Neve KA; Grisham JE; Marshall JF
Brain Res; 1983 May; 267(2):301-11. PubMed ID: 6409351
[TBL] [Abstract][Full Text] [Related]
8. Denervation supersensitivity of striatal D2 dopamine receptors is restricted to the ventro- and dorsolateral regions of the striatum.
Savasta M; Dubois A; Feuerstein C; Manier M; Scatton B
Neurosci Lett; 1987 Feb; 74(2):180-6. PubMed ID: 2883609
[TBL] [Abstract][Full Text] [Related]
9. The effect of melanotropin release inhibiting factor, its metabolites and analogs on [3H]spiroperidol and [3H]apomorphine binding sites.
Bhargava HN
Gen Pharmacol; 1983; 14(6):609-14. PubMed ID: 6141122
[TBL] [Abstract][Full Text] [Related]
10. Optimal conditions for [3H]apomorphine binding and anomalous equilibrium binding of [3H]apomorphine and [3H]spiperone to rat striatal membranes: involvement of surface phenomena versus multiple binding sites.
Leysen JE; Gommeren W
J Neurochem; 1981 Jan; 36(1):201-19. PubMed ID: 7463046
[TBL] [Abstract][Full Text] [Related]
11. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum.
Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
Eur J Pharmacol; 1979 Oct; 58(3):341-2. PubMed ID: 510367
[No Abstract] [Full Text] [Related]
12. Turnover of specific [3H]spiperone and [3H]N,n-propylnorapomorphine binding sites in rat striatum following phenoxybenzamine administration.
Hall MD; Jenner P; Marsden CD
Biochem Pharmacol; 1983 Oct; 32(19):2973-7. PubMed ID: 6626267
[TBL] [Abstract][Full Text] [Related]
13. Apomorphine-induced rotation in the unilateral 6-OHDA-lesioned rat: relationship to changes in striatal adenylate cyclase activity and 3H-spiperone binding.
Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
Neuropharmacology; 1979 Jul; 18(7):643-5. PubMed ID: 573871
[No Abstract] [Full Text] [Related]
14. Modification of morphine-induced changes in striatal (3H)-spiroperidol binding and stereotype-behavior by cyclo(Leu-Gly).
Ritzmann RF; Lee JM; Fields JZ
Life Sci; 1982 May; 30(18):1573-80. PubMed ID: 7200563
[No Abstract] [Full Text] [Related]
15. Multiple daily amphetamine administration decreases both [3H]agonist and [3H]antagonist dopamine receptor binding.
Sibley DR; Weinberger S; Segal DS; Creese I
Experientia; 1982 Oct; 38(10):1224-5. PubMed ID: 6890464
[No Abstract] [Full Text] [Related]
16. Dopamine receptor sensitivity after chronic dopamine agonists. Striatal 3H-spiroperidol binding in mice after chronic administration of high doses of apomorphine, N-n-propylnorapomorphine and dextroamphetamine.
Riffee WH; Wilcox RE; Vaughn DM; Smith RV
Psychopharmacology (Berl); 1982; 77(2):146-9. PubMed ID: 6812131
[TBL] [Abstract][Full Text] [Related]
17. Early supersensitive changes in [3H] spiroperidol binding in the isolated striatum.
Csernansky JG; Friedhoff AJ; Bonnet KA
Biochem Biophys Res Commun; 1982 Mar; 105(1):117-20. PubMed ID: 6124243
[No Abstract] [Full Text] [Related]
18. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
[TBL] [Abstract][Full Text] [Related]
19. Quantification of in vivo spiperone binding in the rat striatum after lesions produced by kainate or decortication.
Van der Werf JF; Van het Schip F; Sebens JB; Korf J
Eur J Pharmacol; 1984 Jul; 102(3-4):387-99. PubMed ID: 6436037
[TBL] [Abstract][Full Text] [Related]
20. Chronic dihydroergotoxine treatment affects the number of dopamine recognition sites in rat striatum.
Battaini F; Govoni S; Rius RA; Spano PF; Trabucchi M
Pharmacol Res Commun; 1984 Jun; 16(6):605-11. PubMed ID: 6463097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]